Suchergebnisse - "Rimassa, Lorenza"

PubPharm (18)

1

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312) : final results of a randomised phase 3 study

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Yau, T. | Kaseb, A. | Cheng, A. | +19

2

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma : a multicentre retrospective study

enthalten in: The Lancet. Oncology | 2023

von Zeng, Q. | Klein, C. | Caruso, S. | +119

3

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy : A global, observational study

enthalten in: Hepatology communications | 2023

von Joerg, V. | Scheiner, B. | D Alessio, A. | +33

4

Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma : a multicenter real-world study

enthalten in: Journal of cancer research and clinical oncology | 2023

von Persano, M. | Rimini, M. | Tada, T. | +77

5

Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma

enthalten in: Hepatology international | 2023

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Hepatol Int. 2023 Aug;17(4):827-829. - PMID 37188999

6

Identification of Atezolizumab Plus Bevacizumab Prognostic Index via Recursive Partitioning Analysis in HCC : The ABE Index

enthalten in: Anticancer research | 2023

von Persano, M. | Rimini, M. | Tada, T. | +18

ErratumIn: Anticancer Res. 2023 May;43(5):2381. - PMID 37097703

7

Real-World Data for Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma : How Does Adherence to the IMbrave150 Trial Inclusion Criteria Impact Prognosis?

enthalten in: Targeted oncology | 2023

von Rimini, M. | Persano, M. | Tada, T. | +67

8

Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma : a large real-life worldwide population

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Casadei-Gardini, A. | Rimini, M. | Tada, T. | +80

9

Safety and Efficacy of Atezolizumab and Bevacizumab Combination as a First Line Treatment of Advanced Hepatocellular Carcinoma

enthalten in: Journal of hepatocellular carcinoma | 2023

von Zanuso, V. | Pirozzi, A. | Balsano, R. | +2

10

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Liver Int. 2022 Nov;42(11):2352-2353. - PMID 36162086